Westchester.com - Female Stress Syndrome Survival Guide Focus Of WAMS Luncheon

Written by Westchester.com

Thursday, 23 August 2007

Rye Brook, NY - The National MS Society, Southern New York Chapter welcomes stress expert, author and Fox News host Dr. Georgia Witkin and Dr. Aaron Miller of Mount Sinai Hospital and Chairman of the Medical Advisory Committee of the National MS Society, as featured guests at the 2nd Annual Women Against Multiple Sclerosis (WAMS) Luncheon on Wednesday September 20 at the Hilton Rye Town in Rye Brook, NY. Tickets for the luncheon which will be held from 12-2pm are $500, $250, and $100 ($500 tickets include a gift and reception with the Dr. Witkin). Reservations are required and may be made by calling Terry Ebersole at (914) 694-1655 x35. The Southern NY Chapter of the National MS Society supports thousands of people with MS in Westchester, Rockland, Putnam, Orange and Sullivan Counties. Sponsors for the WAMS luncheon are Acorda Therapeutics. 103.9 WFAS, 107.1 The Peak and The Westchester County Business Journal. The 2nd Annual Women Against MS (WAMS) Luncheon follows last year’s sold out event that featured special guest Teri Garr. The luncheon will feature nationally recognized stress expert and Fox News host Dr. Georgia Witkin, who will present “The Female Stress Syndrome Survival Guide,” which she bases on the coping mechanisms she learned from her mother, a six-time cancer survivor. Joining Dr. Witkin is MS expert Dr. Aaron Miller who will present “Hope for the Future in Managing MS.” The luncheon will also include a silent auction and all guests will receive a gift from jewelry designer Judith Ripka. Guests purchasing $500 tickets will also enjoy a private reception with Dr. Witkin. According to the National MS Society, multiple sclerosis affects approximately 400,000 Americans. For unknown reasons women are affected twice as often as men - the onset usually occurring in the prime of life between the ages of 20-40. MS Society Chapters throughout the country launched the WAMS luncheons in response to this statistic. They are designed to raise awareness about the disease and to create a supportive network of women who have MS as well as those who have friends, sisters, daughters and mothers with MS. In doing so the organization has built a united front of philanthropists and advocates who are joining their resources to help find a cause and cure for multiple sclerosis. For additional information about the 2nd Annual Women Against MS Luncheon and to make reservations call Terry Ebersole: (914) 694-1655 x 35. About The National MS Society, Southern NY Chapter The Southern New York Chapter is one of 60 Chapters around the country that is helping the National MS Society to find a cure for MS and meet the needs of Americans living with MS. In 2006 the Southern New York Chapter of the National MS Society raised $2.1 million through individual giving and major events that included 5 MS Walks (one in each county represented by the Chapter); the Dystel Memorial Golf Classic for MS; The Swim Across the Hudson™ for MS; the Women Against MS Luncheon (WAMS); and The TZ Bike Tour for MS. Chapter programs and services provide clients with accurate and current information about MS and provide much needed support for families affected by MS. In 2006 the Chapter handled over 1,280 requests for information and referral and sponsored 28 self-help groups and numerous health and wellness programs that included Yoga, T’ai Chi, Aquatics and an Adult Day Program. Volunteers made 77 visits to people residing in long term care facilities and 61 people received critical short-term services from the Chapter that included medical transportation; loan or purchase of durable medical equipment; home/automobile modifications; and home care. About Acorda Therapeutics Acorda Therapeutics® is a biotechnology company whose mission is to develop and market therapies to restore neurological function in people with spinal cord injury (SCI), multiple sclerosis (MS) and related conditions of the nervous system. Acorda is currently conducting a Phase 3 trial of their lead clinical product, Fampridine-SR, to evaluate its safety and efficacy in improving walking ability in people with multiple sclerosis. Many people with MS experience walking impairment and currently there are no therapies approved to address this loss of mobility. Comments (0)

http://westchester.com/Westchester_News/Community/Female_Stress_Syndrome_Survival_Guide_Focus_Of_WAMS_Luncheon_200708238244.html